Hi Felix: i thought it was a good result. also did you see the comment that they will review a divident policy subject to audit confirming the results? Given the cashflow subsequesnt to June 30 was so storng the co. could afford 0.5c and may even say 50% profits going forward. It appears the company has organised itself well and is now poised to grow unde rthe new MD who is obviously doing a good job. i must say i was surprised (pleasantly) by the technoligies and the potential for them (thulium based assaying and spectrolaser). basically XRF is pretty cheap. at 11c x 84m shares = $9.5m ... less cash $4.5m - $5.0m ungeared for the company. EBIT $1.46 means at 11c XRF on 3.4x EBIT. Plus strong potential to grow profits. Given this i am hopeful of bigger things and even if it is a small cap. (micro cap) i think theres little downside to share price and potnetially good upside. theres a lot of demand for lab work. b
XRF Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)